Search

Learn about a potential new strategy for treating people with blood cancers such as acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) that targets a protein on cancer stem cells.

… Thursday, February 2, 2017 Summary Blood cancers such as acute myeloid leukemia and myelodysplastic syndrome often come back after initial treatment, which researchers suspect is caused by stem cells that are never wiped out and go on to initiate and sustain the disease again. It has now been discovered

Researchers have discovered how a high level of the protein PSMA in cells helps fuel prostate cancer.

… Wednesday, November 15, 2017 Summary Prostate cancer cells have high levels of prostate-specific membrane antigen (PSMA), but researchers were unsure of its biological role. Now an MSK-led team has discovered that PSMA contributes to prostate cancer’s development. This offers a new target for drugs.

A lesser-known immune cell is suddenly getting more attention in the field of cancer immunology.

… Thursday, July 12, 2018 A natural killer cell (top right) attacks and kills a cancer cell (center), which blebs and spills its contents. Video courtesy of Morgan Huse. Summary Scientists are coming to appreciate the importance of a specific type of immune cell that keeps people free from disease. Most

A class of drugs originally developed to treat certain neurological disorders appears to boost the production of red blood cells.

… Friday, October 4, 2019 Summary Researchers discovered that blocking a pathway called CHRM4 increases the production of red blood cells. Anemia , a condition in which there are not enough red blood cells to transport oxygen throughout the body, affects millions in the United States every year. It can

… Wednesday, March 30, 2022 Andrew McMahon, front man of the bands Something Corporate and Jack’s Mannequin, was a rock star on the rise when he was suddenly diagnosed with lymphoblastic leukemia at 22 years old. How did he handle this life-changing challenge? And how did his relationship survive the stress

Researchers at MSK pioneered many discoveries in 2023. Read about some of the most important findings.

… Thursday, December 21, 2023 Researchers at Memorial Sloan Kettering Cancer Center (MSK) continued to make strides against cancer in 2023. Laboratory research teams across the institution investigated many fundamental biological questions to advance the global understanding of cancer and the development

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.

… Monday, September 19, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS , an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution

Learn about MSK’s visionary new cancer engineering PhD Program.

… Tuesday, August 22, 2023 Memorial Sloan Kettering Cancer Center (MSK) is substantially expanding its commitment to train the next generation of scientists through a first-of-its-kind PhD program that offers researchers with an engineering, physical science, and computational focus the chance to see their

MSK researchers are learning more about how cancer cells can survive undetected for years only to return in new places. These insights will guide future therapies.

… Thursday, July 1, 2021 For every windsurfing dandelion seed that lands in a nurturing spot and sprouts a new weed, perhaps a thousand more will fall on hostile ground or be trampled under foot. Something similar happens in cancer, which explains why one of the most famous ways of thinking about its spread

After 21 years of dedicated service, Elizabeth McCormick, MSN, RN, CENP, Senior Vice President, Chief Nursing Officer and Enid A. Haupt Chair, Department of Nursing, will retire from MSK at the end of 2021. During her tenure, Ms. McCormick transformed and ultimately redefined the role of nursing at MSK.

… Wednesday, June 30, 2021 Elizabeth McCormick, Senior Vice President and Chief Nursing Officer was given a surprise retirement celebration by MSK staff. Elizabeth McCormick, Senior Vice President and Chief Nursing Officer was given a surprise retirement celebration by MSK staff. After 21 years of dedicated